In oncology, the drug development path is unique: Phase 0 and Phase I trials are typically conducted in patients rather than healthy volunteers, allowing for early assessment of efficacy and patient selection alongside safety. Yet, even with this early clinical...
Winner of the 2013 Nature’s method of the year: single-cell sequencing. It’s no surprise that this method has gained in popularity ever since. Before the award, bulk sequencing methods were the standard for analyzing the transcriptome and other omics. Throughout the...
